What is Limula?
Founded in 2020 and headquartered in Switzerland, Limula is dedicated to advancing the field of cell therapy by developing innovative solutions for 'ex vivo' cell manipulation. The company's core mission is to reduce the cost and complexity associated with these advanced biotechnological processes, thereby democratizing access to cutting-edge treatments. Limula's focus on affordability and accessibility aims to accelerate the adoption of cell-based therapies across a wider range of medical applications.
How much funding has Limula raised?
Limula has raised a total of $6.8M across 1 funding round:
Angel/Seed
$6.8M
Angel/Seed (2024): $6.8M with participation from Lichtsteiner Foundation, Verve Ventures, and Oxford Seed Fund
Key Investors in Limula
Lichtsteiner Foundation
The Lichtsteiner Foundation is an early-stage investor focused on health pioneers, including medtech, life science, and biotech startups. They provide equity funding and facilitate co-funding opportunities to support impactful health innovations.
Verve Ventures
Verve Ventures is a European venture capital firm specializing in digital, tangible, and health & bio startups, investing from Seed to Series B. They offer access to a pan-European network and support for portfolio companies.
Oxford Seed Fund
The Oxford Seed Fund invests in Oxford-affiliated startups, providing up to £50,000 along with crucial network access and support to facilitate scaling and growth.
What's next for Limula?
With this major strategic investment, Limula is poised to accelerate its product development pipeline and expand its market reach. The company is expected to leverage this capital to scale its operations, enhance its technological capabilities, and potentially forge new partnerships within the biotechnology and healthcare industries. This funding round signals strong investor confidence in Limula's vision and its potential to disrupt the 'ex vivo' cell manipulation market, paving the way for future breakthroughs in therapeutic cell treatments.
See full Limula company page
